All About PresVu, New Eye Drops That Can Remove Reading Glasses In 15 Mins | UPSC

Summary

The video script discusses a revolutionary eye drop called 'Press Vue' developed by an Indian company, Antod Pharmaceuticals, to combat presbyopia, a common age-related vision condition. The drop is designed to provide relief within 15 minutes, potentially eliminating the need for reading glasses. Approved by the Drug Controller General of India, it uses a patented formula and sophisticated technology to adjust the eye's focus for near objects. The product is set to launch in October, with a cost of ₹3345 for a month's supply. The script also highlights the importance of this development for the Indian population, as it is tailored to suit Indian eyes, which differ from Western populations.

Takeaways

• 😀 The script introduces 'Study I.C.U.I.S.', a preparation for a video about presbyopia and a new eye drop solution.
• 🌐 The eye drop, named 'Press View', is developed by an Indian company called 'Antod Pharmaceuticals' specifically for the Indian population.
• 👓 It aims to provide relief to those suffering from presbyopia, a condition where the eye's lens loses its flexibility, making it difficult to focus on nearby objects.
• 🏥 The drug controller general of India, DCGI, has authorized the first eye drop in India to treat presbyopia, eliminating the need for reading glasses.
• 🌿 The eye drop contains a special formula that includes 'Pilocarpine', a plant-derived compound used in various medical treatments for eye conditions.
• 🔬 The product has undergone clinical trials, with phase three trials conducted on approximately 250 patients, showing promising results for mild to intermediate presbyopia.
• ⏱️ The effects of the eye drop are said to last for at least 6 hours, and reapplication can extend the benefits.
• 💊 The eye drop will not be available over the counter and will require a prescription, ensuring it is used correctly and safely.
• 📅 The product is expected to hit the market in October, with a cost of ₹3345 for a month's supply.
• 📈 The company has provided guidelines to their field staff on how to educate doctors and patients about the proper use of the eye drop.

Q & A

What is the purpose of the 'Press Vue' eye drop mentioned in the script?

The 'Press Vue' eye drop is developed to treat presbyopia, a condition where the eye's lens loses its flexibility, making it difficult to focus on nearby objects. It aims to provide relief without the need for reading glasses.

Which company has developed the 'Press Vue' eye drop?

The 'Press Vue' eye drop has been developed by a Mumbai-based company called 'Antod Pharmaceuticals.'

What is the significance of the DCGI approval for 'Press Vue'?

The DCGI (Drug Controller General of India) approval signifies that the 'Press Vue' eye drop has met the necessary regulatory standards and is considered safe for use by the Indian population.

How does the 'Press Vue' eye drop work to treat presbyopia?

The 'Press Vue' eye drop works by reducing the size of the pupil, allowing for better focus on nearby objects. It is based on a special formulation that adjusts automatically to the eye's natural response.

What is the main ingredient in 'Press Vue' that helps in treating presbyopia?

The main ingredient in 'Press Vue' is 'Pilocarpine,' a plant-derived compound that has been used for decades to treat various eye conditions, including dry mouth and high eye pressure.

How long does the effect of 'Press Vue' eye drop last?

The effect of 'Press Vue' eye drop lasts for at least 6 hours, but the company's CEO mentioned that applying a second drop within 3 to 6 hours can extend the effect for a longer duration.

Is 'Press Vue' suitable for the Indian population specifically?

Yes, 'Press Vue' has been specifically developed for the Indian population, taking into account the genetic differences and the unique eye conditions prevalent in India.

When will 'Press Vue' be available in the Indian market?

According to the company, 'Press Vue' will be available in the Indian market starting from the first week of October.

What is the cost of a single vial of 'Press Vue'?

The cost of a single vial of 'Press Vue' is ₹3345, which is expected to last for about a month.

Will 'Press Vue' be available without a prescription?

No, 'Press Vue' will not be available without a prescription. It will be sold as a prescription-only medication.

What is the role of the field staff in the marketing of 'Press Vue'?

The field staff will be providing guidelines and education to doctors on how to use 'Press Vue' effectively, ensuring proper understanding and application of the product.